Abstract
Mammalian cells have a remarkable diverse repertoire of response to genotoxic stress that damage DNA. Cellular responses to DNA damaging agents will initially exhibit gene induction, which is regulated by complex mechanism(s) and probably involves multiple signaling pathways. In this paper, we demonstrate that induction of ATF3 protein, a member of the ATF/CREB family of transcription factors, by ionizing radiation (IR) requires normal cellular p53 function. In contrast, induction of ATF3 after UV radiation (UV) or Methyl methanesulphonate (MMS) is independent of p53 status. Induction of ATF3 by DNA damage is rapid, transient, and through a transcriptional mechanism. The ATF3 promoter is induced by UV and MMS, but not by IR. In addition, ATF3 promoter can be activated by MEKK1, an upstream activator of the ERK and JNK kinase pathway, but not induced following p53 expression. Those results indicate that regulation of ATF3 induction after DNA damage utilizes both the p53-dependent and -independent pathways, and may also involve MAP kinase signaling pathways. Using the tetracycline-inducible system (tet-off), we have found that over-expression of ATF3 protein moderately suppresses cell growth. Interestingly, over-expression of ATF3 protein is able to slow down progression of cells from G1 to S phase, indicating that ATF3 protein might play a negative role in the control of cell cycle progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Allan AL, Albanese C, Pestell RG, LaMarre J . 2001 J. Biol. Chem. 276: 27272–27280
Allen-Jennings AE, Hartman MG, Kociba GJ, Hai T . 2001 J. Biol. Chem. 276: 29507–29514
Amundson SA, Zhan Q, Penn LZ, Fornace Jr AJ . 1998 Oncogene 17: 2149–2154
Chen BP, Wolfgang CD, Hai T . 1996 Mol. Cell. Biol. 16: 1157–1168
Drysdale BE, Howard DL, Johnson RJ . 1996 Mol. Immunol. 33: 989–998
el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B . 1994 Cancer Res. 54: 1169–1174
el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B . 1993 Cell 75: 817–825
Evan G, Littlewood T . 1998 Science 281: 1317–1322
Fornace Jr AJ, Jackman J, Hollander MC, Hoffman-Liebermann B, Liebermann DA . 1992 Ann. NY Acad. Sci. 663: 139–153
Haas S, Kaina B . 1995 Carcinogenesis 16: 985–991
Hai T, Hartman MG . 2001 Gene 273: 1–11
Hai T, Wolfgang CD, Marsee DK, Allen AE, Sivaprasad U . 1999 Gene Expr. 7: 321–335
Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Maheswaran S, Oliner JD, Haber DA . 1999 Cell 97: 575–586
Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ . 1993 Cell 75: 805–816
Hartwell LH, Kastan MB . 1994 Science 266: 1821–1828
Holbrook NJ, Liu Y, Fornace Jr AJ . 1996 Exs. 77: 273–288
Hollander MC, Fornace Jr AJ . 1989 Cancer Res. 49: 1687–1692
Ishiguro T, Nagawa H . 2000 Oncol. Res. 12: 343–346
Jin S, Antinore MJ, Lung FD, Dong X, Zhao H, Fan F, Colchagie AB, Blanck P, Roller PP, Fornace Jr AJ, Zhan Q . 2000 J. Biol. Chem. 275: 16602–16608
Jin S, Fan F, Fan W, Zhao H, Tong T, Blanck P, Alomo I, Rajasekaran B, Zhan Q . 2001 Oncogene 20: 2683–2690
Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW . 1991 Cancer Res. 51: 6304–6311
Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace Jr AJ . 1992 Cell 71: 587–597
Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, Vogelstein B . 1992 Science 256: 827–830
Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN . 1993 Semin. Cancer Biol. 4: 327–332
Kumari SR, Alvarez-Gonzalez R . 2000 Cancer Invest. 18: 715–721
Liang G, Wolfgang CD, Chen BP, Chen TH, Hai T . 1996 J. Biol. Chem. 271: 1695–1701
Mashima T, Udagawa S, Tsuruo T . 2001 J. Cell. Physiol. 188: 352–358
Miyashita T, Reed JC . 1995 Cell 80: 293–299
Rajanbabu R, Patarca R . 1999 Crit. Rev. Oncog. 10: 275–291
Rupnow BA, Alarcon RM, Giaccia AJ, Knox SJ . 1998 Cell Death Differ. 5: 141–147
Schmutte C, Fishel R . 1999 Anticancer Res. 19: 4665–4696
Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Wu GS, Licht JD, Weber BL, El-Deiry WS . 1997 Nature 389: 187–190
Tong T, Fan W, Zhao H, Jin S, Fan F, Blanck P, Alomo I, Rajasekaran B, Liu Y, Holbrook NJ, Zhan Q . 2001 Exp. Cell Res. 269: 64–72
Vaux DL, Strasser A . 1996 Proc. Natl. Acad. Sci. USA 93: 2239–2244
Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace Jr AJ, Harris CC . 1999 Proc. Natl. Acad. Sci. USA 96: 3706–3711
White E . 1996 Genes. Dev. 10: 1–15
Wolfgang CD, Chen BP, Martindale JL, Holbrook NJ, Hai T . 1997 Mol. Cell. Biol. 17: 6700–6707
Wolfgang CD, Liang G, Okamoto Y, Allen AE, Hai T . 2000 J. Biol. Chem. 275: 16865–16870
Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D . 1993 Nature 366: 701–704
Yan C, Wang H, Boyd DD . 2002 J. Biol. Chem. 277: 10804–10812
Yin XM, Oltvai ZN, Korsmeyer SJ . 1995 Curr. Top. Microbiol. Immunol. 194: 331–338
Yu Q, He M, Lee NH, Liu ET . 2002 J. Biol. Chem. 15: 13059–13066
Zhan Q, Antinore MJ, Wang XW, Carrier F, Smith ML, Harris CC, Fornace Jr AJ . 1999 Oncogene 18: 2892–2900
Zhan Q, Bae I, Kastan MB, Fornace Jr AJ . 1994a Cancer Res. 54: 2755–2760
Zhan Q, Carrier F, Fornace Jr AJ . 1993 Mol. Cell. Biol. 13: 4242–4250
Zhan Q, Chen IT, Antinore MJ, Fornace Jr AJ . 1998 Mol. Cell. Biol. 18: 2768–2778
Zhan Q, Fan S, Bae I, Guillouf C, Liebermann DA, O'Connor PM, Fornace Jr AJ . 1994b Oncogene 9: 3743–3751
Zhan Q, Fan S, Smith ML, Bae I, Yu K, Alamo Jr I, O'Connor PM, Fornace Jr AJ . 1996 DNA Cell. Biol. 15: 805–815
Zhan Q, Lord KA, Alamo Jr I, Hollander MC, Carrier F, Ron D, Kohn KW, Hoffman B, Liebermann DA, Fornace Jr AJ . 1994c Mol. Cell. Biol. 14: 2361–2371
Zhao H, Jin S, Fan F, Fan W, Tong T, Zhan Q . 2000 Cancer Res. 60: 6276–6280
Acknowledgements
We thank Tsonwin Hai for providing important reagents in this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fan, F., Jin, S., Amundson, S. et al. ATF3 induction following DNA damage is regulated by distinct signaling pathways and over-expression of ATF3 protein suppresses cells growth. Oncogene 21, 7488–7496 (2002). https://doi.org/10.1038/sj.onc.1205896
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205896
Keywords
This article is cited by
-
ATF-3 expression inhibits melanoma growth by downregulating ERK and AKT pathways
Laboratory Investigation (2021)
-
Modeling preeclampsia using human induced pluripotent stem cells
Scientific Reports (2021)
-
Persistence of a regeneration-associated, transitional alveolar epithelial cell state in pulmonary fibrosis
Nature Cell Biology (2020)
-
Manumycin polyketides act as molecular glues between UBR7 and P53
Nature Chemical Biology (2020)
-
Competitive ubiquitination activates the tumor suppressor p53
Cell Death & Differentiation (2020)